Cipher Pharmaceuticals Reports Q1 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Cipher Pharma (CPHR) Misses Q1 EPS by 6c
May 5, 2016 9:42 AM EDTCipher Pharma (NASDAQ: CPHR) reported Q1 EPS of ($0.10), $0.06 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $10.72 million.
For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.
... More